✦ LIBER ✦

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ Scribed by Rudolf A. Joss; Renato L. Galeazzi; Annakatharina Bischoff; Do D. Do; Aron Goldhirsch; Kurt W. Brunner

Publisher: Springer
Year: 1982
Tongue: English
Weight: 363 KB
Volume: 9
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00296765

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion of high-dose metoclo

Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ R. A. Joss; R. L. Galeazzi; K. W. Brunner 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 580 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Daily palonosetron is superior to ondans

Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia

✍ Gloria N. Mattiuzzi; Jorge E. Cortes; Deborah A. Blamble; B. Nebiyou Bekele; Lia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

A randomized, double-blind comparison of

A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin

✍ Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high

Nausea and emesis remain significant pro

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics : A University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program study of 360 cancer patients treated in the community

✍ Jane T. Hickok; Joseph A. Roscoe; Gary R. Morrow; David K. King; James N. Atkins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## BACKGROUND Clinical reports suggest that nausea remains a side effect of chemotherapy despite widespread use of serotonin receptor antagonists. This study summarized the frequency, timing, and intensity of postchemotherapy nausea for patients receiving doxorubicin, cisplatin, or car